Skip to main content

Animations

MJFF Publications

4321 - 4330 of 9140 Results
Title
Year
  • Year
  • 2014
  • 2016
  • 2020
  • 2023
  • 2021
  • 2022
  • 2023
  • 2017
  • 2023
  • 2025
  • Movement disorders: discoveries in pathophysiology and therapy
    2014
    Summary Details
    RESTRICTED
    Title: Movement disorders: discoveries in pathophysiology and therapy
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(14)70307-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Personality and reported quality of life in Parkinson's disease
    Journal Name: International Journal of Geriatric Psychiatry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/gps.4475
    Best OA location URL: http://doi.org/10.1002/gps.4475
    Citation Count: 24
  • Summary Details
    OPEN
    Title: SMPD1 variants do not have a major role in rapid eye movement sleep behavior disorder
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.04.005
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad072
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Bioinspired Theranostic Coordination Polymer Nanoparticles for Intranasal Dopamine Replacement in Parkinson’s Disease
    Journal Name: ACS Nano
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsnano.1c00453
    Citation Count: 101
  • Summary Details
    OPEN
    Title: Synapsin III gene silencing redeems alpha-synuclein transgenic mice from Parkinson's disease-like phenotype
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ymthe.2022.01.021
    Citation Count: 25
  • Summary Details
    OPEN
    Title: International Genetic Testing and Counseling Practices for Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29442
    Citation Count: 16
  • Summary Details
    OPEN
    Title: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-017-0456-2
    Citation Count: 100
  • Sleep disorders and mortality: A prospective study in the Canadian longitudinal study on aging
    2023
    Summary Details
    RESTRICTED
    Title: Sleep disorders and mortality: A prospective study in the Canadian longitudinal study on aging
    Journal Name: Sleep Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.sleep.2023.12.023
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Site-specific neuronal and motor effects of short-term intermittent burst deep brain stimulation in non-human primates
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.brs.2025.05.009
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.